03.01.05
A recently completed placebo-controlled, double-blind human clinical trial has shown that consuming a combination of conjugated linoleic acid (CLA) and green tea extract for a period of 12 weeks results in a significant loss of body weight in overweight human subjects. Results from this study are now being submitted for publication in a scientific journal. Dr. Venket Rao, professor emeritus at the Department of Nutritional Sciences, University of Toronto, and Dr. Kathee Andrews conducted the trial to evaluate the effect of ingesting the product abs+, manufactured by ehn, inc., Toronto, Ontario, Canada. abs+ contains the two active ingredients CLA and epigallocatechin gallate (EGCG) at levels previously shown individually to bring about changes in body weight in human subjects. Thirty-four human subjects, male and female, over 30 years of age having a BMI of 25 or more and a waist circumference of 80 cm or more for females and 94 cm or more for males, were assigned randomly to either a control group, which received six placebo capsules containing no active ingredients, or a treatment group, which received six abs+ capsules, each containing 576 mg CLA and 45 mg of EGCG for a total daily intake of 3400 mg CLA and 270 mg EGCG. A significant reduction in body weight of subjects ingesting abs+ compared to placebo was observed. Close to 60% of the subjects in the placebo group either gained weight or had no change during the course of the 12 weeks, whereas in the abs+ group 70% of the subjects either lost weight or had no change in their body weights.